Skip to main content
Top
Published in: Digestive Diseases and Sciences 4/2024

05-03-2024 | Acute Pancreatitis | Original Article

Ameliorative Effects of Larazotide Acetate on Intestinal Permeability and Bacterial Translocation in Acute Pancreatitis Model in Rats

Authors: Doğu Karahan, Muhsin Murat Muhip Harputluoglu, Mehmet Gul, Ayten Gunduz, Fatma Ozyalin, Feyza İnceoğlu, Deniz Tikici, İsmet Yılmaz, Basri Satilmis

Published in: Digestive Diseases and Sciences | Issue 4/2024

Login to get access

Abstract

Background

Intestinal barrier dysfunction in acute pancreatitis (AP) may progress to systemic inflammatory response syndrome (SIRS) and multi-organ failures by causing bacterial translocation. Larazotide acetate (LA) is a molecule that acts as a tight junction (TJ) regulator by blocking zonulin (Zo) receptors in the intestine.

Aims

In our study, we aimed to investigate the effects of LA on intestinal barrier dysfunction and bacterial translocation in the AP model in rats.

Methods

Thirty-two male Sprague-Dawley rats were divided into 4 groups; control, larazotide (LAR), AP, and AP + LAR. The AP model was created by administering 250 mg/100 g bm l-Arginine intraperitoneally 2 times with an hour interval. AP + LAR group received prophylactic 0.01 mg/mL LA orally for 7 days before the first dose of l-Arginine. For intestinal permeability analysis, fluorescein isothiocyanate-dextran (FITC-Dextran) was applied to rats by gavage. The positivity of any of the liver, small intestine mesentery, and spleen cultures were defined as bacterial translocation. Histopathologically damage and zonulin immunoreactivity in the intestine were investigated.

Results

Compared to the control group, the intestinal damage scores, anti-Zo-1 immunoreactivity H-Score, serum FITC-Dextran levels and bacterial translocation frequency (100% versus 0%) in the AP group were significantly higher (all p < 0.01). Intestinal damage scores, anti-Zo-1 immunoreactivity H-score, serum FITC-Dextran levels, and bacterial translocation frequency (50% versus 100%) were significantly lower in the AP + LAR group compared to the AP group (all p < 0.01).

Conclusions

Our findings show that LA reduces the increased intestinal permeability and intestinal damage by its effect on Zo in the AP model in rats, and decreases the frequency of bacterial translocation as a result of these positive effects.

Graphical Abstract

Literature
1.
go back to reference Garg PK, Singh VP. Organ failure due to systemic injury in acute pancreatitis. Gastroenterology 2019;156:2008–2023.CrossRefPubMed Garg PK, Singh VP. Organ failure due to systemic injury in acute pancreatitis. Gastroenterology 2019;156:2008–2023.CrossRefPubMed
2.
3.
go back to reference Yang W, Xu HW, Lu XR, Xu QF, Tao MH, Dai M. Overexpression of miR-122 impairs intestinal barrier function and aggravates acute pancreatitis by downregulating occludin expression. Biochem Genet. 2022;60:382–394.CrossRefPubMed Yang W, Xu HW, Lu XR, Xu QF, Tao MH, Dai M. Overexpression of miR-122 impairs intestinal barrier function and aggravates acute pancreatitis by downregulating occludin expression. Biochem Genet. 2022;60:382–394.CrossRefPubMed
4.
go back to reference Koh YY, Jeon WK, Cho YK et al. The effect of intestinal permeability and endotoxemia on the prognosis of acute pancreatitis. Gut Liver. 2012;6:505–511.CrossRefPubMedPubMedCentral Koh YY, Jeon WK, Cho YK et al. The effect of intestinal permeability and endotoxemia on the prognosis of acute pancreatitis. Gut Liver. 2012;6:505–511.CrossRefPubMedPubMedCentral
5.
go back to reference Singh N, Sonika U, Moka P et al. Association of endotoxemia & gut permeability with complications of acute pancreatitis: Secondary analysis of data Indian. J Med Res. 2019;149:763–770. Singh N, Sonika U, Moka P et al. Association of endotoxemia & gut permeability with complications of acute pancreatitis: Secondary analysis of data Indian. J Med Res. 2019;149:763–770.
6.
go back to reference Caliskan AR, Gul M, Yılmaz I et al. Effects of larazotide acetate, a tight junction regulator, on the liver and intestinal damage in acute liver failure in rats. Hum Exp Toxicol. 2021;40:693–701.CrossRef Caliskan AR, Gul M, Yılmaz I et al. Effects of larazotide acetate, a tight junction regulator, on the liver and intestinal damage in acute liver failure in rats. Hum Exp Toxicol. 2021;40:693–701.CrossRef
7.
go back to reference Sturgeon C, Fasano A. Zonulin, a regulator of epithelial and endothelial barrier functions, and its involvement in chronic inflammatory diseases. Tissue Barriers. 2016;4:e1251384.CrossRefPubMedPubMedCentral Sturgeon C, Fasano A. Zonulin, a regulator of epithelial and endothelial barrier functions, and its involvement in chronic inflammatory diseases. Tissue Barriers. 2016;4:e1251384.CrossRefPubMedPubMedCentral
8.
go back to reference Slifer ZM, Krishnan BR, Madan J, Blikslager AT. Larazotide acetate: a pharmacological peptide approach to tight junction regulation. Am J Physiol Gastrointest Liver Physiol. 2021;320:983–989.CrossRef Slifer ZM, Krishnan BR, Madan J, Blikslager AT. Larazotide acetate: a pharmacological peptide approach to tight junction regulation. Am J Physiol Gastrointest Liver Physiol. 2021;320:983–989.CrossRef
9.
go back to reference Slifer ZM, Hernandez L, Pridgen TA et al. Larazotide acetate induces recovery of ischemia-injured porcine jejunum via repair of tight junctions. PLoS ONE 2021;16:e0250165.CrossRefPubMedPubMedCentral Slifer ZM, Hernandez L, Pridgen TA et al. Larazotide acetate induces recovery of ischemia-injured porcine jejunum via repair of tight junctions. PLoS ONE 2021;16:e0250165.CrossRefPubMedPubMedCentral
10.
go back to reference Faul F, Erdfelder E, Lang AG. G*Power 31: test for correlation and regression analyses flexible statistical power analysis. Behav Res Methods 2009;41:1149–1160.CrossRefPubMed Faul F, Erdfelder E, Lang AG. G*Power 31: test for correlation and regression analyses flexible statistical power analysis. Behav Res Methods 2009;41:1149–1160.CrossRefPubMed
11.
go back to reference Yılmaz EE, Bozdağ Z, Ibiloğlu I et al. Therapeutic effects of ellagic acid on l-arginine ınduced acute pancreatitis. Acta Cir Bras. 2016;31:396–401.CrossRefPubMed Yılmaz EE, Bozdağ Z, Ibiloğlu I et al. Therapeutic effects of ellagic acid on l-arginine ınduced acute pancreatitis. Acta Cir Bras. 2016;31:396–401.CrossRefPubMed
12.
go back to reference Ragy MM, Ali FF, Toni NDM. Comparing the preventive effect of sodium hydrosulfide, leptin, and curcumin against l-arginine induced acute pancreatitis in rats: role of corticosterone and inducible nitric oxide synthase. Endocr Regul. 2019;53:221–230.CrossRefPubMed Ragy MM, Ali FF, Toni NDM. Comparing the preventive effect of sodium hydrosulfide, leptin, and curcumin against l-arginine induced acute pancreatitis in rats: role of corticosterone and inducible nitric oxide synthase. Endocr Regul. 2019;53:221–230.CrossRefPubMed
13.
go back to reference Wang J, Xu H, Chen T et al. Effect of monoacylglycerol lipase ınhibition on ıntestinal permeability of rats with severe acute pancreatitis. Front Pharmacol. 2022;13:869482.CrossRefPubMedPubMedCentral Wang J, Xu H, Chen T et al. Effect of monoacylglycerol lipase ınhibition on ıntestinal permeability of rats with severe acute pancreatitis. Front Pharmacol. 2022;13:869482.CrossRefPubMedPubMedCentral
14.
go back to reference Budwit-Novotny DA, McCarty KS, Cox EB et al. Immunohistochemical analyses of estrogen receptor in endometrial adenocarcinoma using a monoclonal antibody. Cancer Res 1986;46:5419–5425.PubMed Budwit-Novotny DA, McCarty KS, Cox EB et al. Immunohistochemical analyses of estrogen receptor in endometrial adenocarcinoma using a monoclonal antibody. Cancer Res 1986;46:5419–5425.PubMed
15.
go back to reference Liu D, Wen L, Wang Z et al. The mechanism of lung and ıntestinal ınjury in acute pancreatitis: a review. Front Med. 2022;9:904078.CrossRef Liu D, Wen L, Wang Z et al. The mechanism of lung and ıntestinal ınjury in acute pancreatitis: a review. Front Med. 2022;9:904078.CrossRef
16.
go back to reference Ge P, Luo Y, Okoye CS et al. Intestinal barrier damage, systemic inflammatory response syndrome, and acute lung injury: a troublesome trio for acute pancreatitis. Biomed Pharmacother. 2020;132:110770.CrossRefPubMed Ge P, Luo Y, Okoye CS et al. Intestinal barrier damage, systemic inflammatory response syndrome, and acute lung injury: a troublesome trio for acute pancreatitis. Biomed Pharmacother. 2020;132:110770.CrossRefPubMed
17.
go back to reference Sun X, Shao Y, Jin Y et al. Melatonin reduces bacterial translocation by preventing damage to the intestinal mucosa in an experimental severe acute pancreatitis rat model. Exp Ther Med. 2013;6:1343–1349.CrossRefPubMedPubMedCentral Sun X, Shao Y, Jin Y et al. Melatonin reduces bacterial translocation by preventing damage to the intestinal mucosa in an experimental severe acute pancreatitis rat model. Exp Ther Med. 2013;6:1343–1349.CrossRefPubMedPubMedCentral
18.
go back to reference Suzuki T. Regulation of the intestinal barrier by nutrients: the role of tight junctions. Anim Sci J = Nihon chikusan Gakkaiho. 2020;91:e13357.PubMed Suzuki T. Regulation of the intestinal barrier by nutrients: the role of tight junctions. Anim Sci J = Nihon chikusan Gakkaiho. 2020;91:e13357.PubMed
19.
go back to reference Fasano A. Zonulin and its regulation of intestinal barrier function: the biological door to inflammation, autoimmunity, and cancer. Physiol Rev. 2011;91:151–175.CrossRefPubMed Fasano A. Zonulin and its regulation of intestinal barrier function: the biological door to inflammation, autoimmunity, and cancer. Physiol Rev. 2011;91:151–175.CrossRefPubMed
20.
go back to reference Serek P, Oleksy-Wawrzyniak M. The effect of bacterial infections, probiotics and zonulin on intestinal barrier integrity. Int J Mol Sci. 2021;22:11359.CrossRefPubMedPubMedCentral Serek P, Oleksy-Wawrzyniak M. The effect of bacterial infections, probiotics and zonulin on intestinal barrier integrity. Int J Mol Sci. 2021;22:11359.CrossRefPubMedPubMedCentral
21.
go back to reference Gopalakrishnan S, Tripathi A, Tamiz AP et al. Larazotide acetate promotes tight junction assembly in epithelial cells. Peptides 2012;35:95–101.CrossRefPubMed Gopalakrishnan S, Tripathi A, Tamiz AP et al. Larazotide acetate promotes tight junction assembly in epithelial cells. Peptides 2012;35:95–101.CrossRefPubMed
22.
go back to reference Schietroma M, Pessia B, Carlei F et al. Intestinal permeability and systemic endotoxemia in patients with acute pancreatitis. Ann Ital Chir. 2016;87:138–144.PubMed Schietroma M, Pessia B, Carlei F et al. Intestinal permeability and systemic endotoxemia in patients with acute pancreatitis. Ann Ital Chir. 2016;87:138–144.PubMed
23.
go back to reference Twardowska A, Makaro A, Binienda A et al. Preventing bacterial translocation in patients with leaky gut syndrome: nutrition and pharmacological treatment options. Int J Mol Sci. 2022;23:3204.CrossRefPubMedPubMedCentral Twardowska A, Makaro A, Binienda A et al. Preventing bacterial translocation in patients with leaky gut syndrome: nutrition and pharmacological treatment options. Int J Mol Sci. 2022;23:3204.CrossRefPubMedPubMedCentral
24.
go back to reference Fukui H. Increased intestinal permeability and decreased barrier function: does it really influence the risk of inflammation? Inflamm Intest Dis. 2016;1:135–145.CrossRefPubMedPubMedCentral Fukui H. Increased intestinal permeability and decreased barrier function: does it really influence the risk of inflammation? Inflamm Intest Dis. 2016;1:135–145.CrossRefPubMedPubMedCentral
Metadata
Title
Ameliorative Effects of Larazotide Acetate on Intestinal Permeability and Bacterial Translocation in Acute Pancreatitis Model in Rats
Authors
Doğu Karahan
Muhsin Murat Muhip Harputluoglu
Mehmet Gul
Ayten Gunduz
Fatma Ozyalin
Feyza İnceoğlu
Deniz Tikici
İsmet Yılmaz
Basri Satilmis
Publication date
05-03-2024
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 4/2024
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-024-08326-8

Other articles of this Issue 4/2024

Digestive Diseases and Sciences 4/2024 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine